Brief: Orthofix Medical Q4 Sales USD 219.9 Million Vs. IBES Estimate USD 218.7 Million
24/02/2026 12:00
Feb 24 (Reuters) - Orthofix Medical Q4 adjusted EBITDA USD 29.2 million vs. IBES estimate USD 28.4 million. Q4 gross margin 71.1%
Recent news on Orthofix Medical
See all newsOrthofix Medical Inc. reports results for the quarter ended June 30 - Earnings Summary
Orthofix Medical Q2 sales slightly beat estimates
Orthofix Medical Inc expected to post a loss of 41 cents a share - Earnings Preview
Orthofix Medical Q1 sales beat estimates, reaffirms FY outlook
Brief: Orthofix Medical Inc - Announces Strategic Realignment Of Spine Leadership Team